Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-017869
Filing Date
2018-03-07
Accepted
2018-03-07 20:09:30
Documents
2
Period of Report
2018-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9861
2 POA DOCUMENT poa.txt EX-24.3_776802 3449
  Complete submission text file 0001209191-18-017869.txt   14608
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Issuer) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address
Kwan Pui San (Reporting) CIK: 0001733642 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35420 | Film No.: 18674798